Keyphrases
Leucine-rich Repeat Kinase 2 (LRRK2)
100%
Human Neural Stem Cells (hNSCs)
100%
G2019S mutation
60%
Aging
40%
Parkinson Patients
40%
Parkinson's Disease
40%
Induced Pluripotent Stem Cells (iPSCs)
40%
Nuclear Envelope
40%
Idiopathic Parkinson's Disease
40%
Amino Acids
20%
Human Disease
20%
Cellular Structure
20%
Clonal Expansion
20%
Disease Phenotype
20%
Neuronal Differentiation
20%
Increased Vulnerability
20%
Cell Organelles
20%
Glycine
20%
Potential Development
20%
Stem Cell-derived
20%
Human Embryonic Stem Cells (hESCs)
20%
Stem Cell Population
20%
Nuclear Organization
20%
Therapeutic Targeting
20%
Human Brain Tissue
20%
Disease Pathology
20%
Adult Neurogenesis
20%
Fundamental Cell
20%
Targeted Knock-in
20%
Human Aging
20%
G2019S
20%
Parkinson's Disease Detection
20%
Nuclear Aberrations
20%
Associated Disorders
20%
Nuclear Architecture
20%
Dominant mutation
20%
Biochemistry, Genetics and Molecular Biology
Leucine-Rich Repeat
100%
Stem Cell
100%
Phosphotransferase
100%
Kinase
100%
Induced Pluripotent Stem Cell
40%
Nuclear Membrane
40%
Wild Type
20%
Serine
20%
Nervous System Development
20%
Embryonic Stem Cell
20%
Mouse
20%
Nerve Cell Differentiation
20%
Neuroscience
Neural Stem Cell
100%
Neurogenesis
16%
Pharmacology, Toxicology and Pharmaceutical Science
Parkinson's Disease
100%
Serine
16%